Increased levels of p65 and phospho-p65 are commonly observed in medical conditions characterized by inflammation, autoimmune disorders, and cancer, wherein activation of the NF-κB pathway contributes to the expression of pro-inflammatory mediators and the recruitment of immune cells to sites of inflammation. This evidence concerns the gene NFKB1 and autoimmune disease.